Confluence Pharmaceuticals

About:

Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders

Website: http://www.confluencepharma.com/

Top Investors: Purdue Research Foundation, Elevate Ventures, IU Ventures, Indiana University Philanthropic Venture Fund

Description:

Confluence Pharmaceuticals is developing novel therapeutic medications for neurological development disorders. The company's current focus is advancing a novel drug discovery that improves social and communication impairments for individuals with Autism Spectrum Disorders and Fragile X Syndrome.